XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.23.3

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue [Table Text Block] | The following table represents our revenues disaggregated by product line (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
Product line | 2023 |  | 2022 |  | 2023 |  | 2022
Consumables | 242,010 |  |  | 251,572 |  |  | 715,108 |  |  | 732,756 |
Infusion Systems | 148,981 |  |  | 161,555 |  |  | 463,836 |  |  | 448,426 |
Vital Care | 162,320 |  |  | 184,730 |  |  | 492,326 |  |  | 520,801 |
Total Revenues | $ | 553,311 |  |  | $ | 597,857 |  |  | $ | 1,671,270 |  |  | $ | 1,701,983 |
For the three and nine months ended September 30, 2023, net sales to Medline made up approximately 18% and 16% of total revenues, respectively. For the three and nine months ended September 30, 2022, net sales to Medline made up approximately 16% and 15% of total revenues, respectively. The following table represents our revenues disaggregated by geography (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
Geography | 2023 |  | 2022 |  | 2023 |  | 2022
United States | $ | 355,984 |  |  | $ | 376,691 |  |  | $ | 1,063,037 |  |  | $ | 1,088,348 |
Europe, the Middle East and Africa | 88,014 |  |  | 101,869 |  |  | 276,994 |  |  | 275,488 |
APAC | 59,064 |  |  | 66,569 |  |  | 177,719 |  |  | 191,847 |
Other Foreign | 50,249 |  |  | 52,728 |  |  | 153,520 |  |  | 146,300 |
Total Revenues | $ | 553,311 |  |  | $ | 597,857 |  |  | $ | 1,671,270 |  |  | $ | 1,701,983 |
Contract with Customer, Asset and Liability [Table Text Block] | The following table presents the changes in our contract balances for the nine months ended September 30, 2023 and 2022 (in thousands):
| Contract Liabilities
Beginning balance, January 1, 2023 | $ | (45,866) |
Equipment revenue recognized | 24,872 |
Equipment revenue deferred | (25,620) |
Software revenue recognized | 13,546 |
Software revenue deferred | (12,797) |
Government grant deferred income* | (944) |
Government grant recognized | 3,164 |
Other deferred revenue | (1,674) |
Other deferred revenue recognized | 4,748 |
Ending balance, September 30, 2023 | $ | (40,571) |
Beginning balance, January 1, 2022 | $ | (7,461) |
Fair value of acquired deferred revenue | (51,245) |
Equipment revenue recognized | 22,757 |
Equipment revenue deferred | (13,420) |
Software revenue recognized | 12,761 |
Software revenue deferred | (12,978) |
Government grant deferred income* | (3,434) |
Government grant recognized | 178 |
Other deferred revenue | (1,285) |
Other deferred revenue recognized | 3,488 |
Ending balance, September 30, 2022 | $ | (50,639) |
Deferred Revenue, by Arrangement, Disclosure | As of September 30, 2023, revenue from remaining performance obligations is as follows:
| Recognition Timing
(in millions) | < 12 Months |  | > 12 Months
Equipment deferred revenue | $ | (16,448) |  |  | $ | (12) |
Software deferred revenue | (8,261) |  |  | (707) |
Government grant deferred income* | (1,451) |  |  | (10,548) |
Other deferred revenue** | (2,575) |  |  | (569) |
Total | $ | (28,735) |  |  | $ | (11,836) |
_________________________________ *The government grant deferred income is amortized over the life of the related depreciable asset as a reduction to depreciation expense. **Other deferred revenue includes pump development programs, purchased training and extended warranty.

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date. + References No definition available. + Details
Name: | us-gaap_DeferredRevenueByArrangementDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration